|
⚲
|
| Keyboard |
| Bartizal Ken
✚
|
|
|---|---|
| CIK # | 0001478832 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001478832] | |
| 4 | [0001478832] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Bartizal Ken | |
| K2 Therapeutics Inc | |
| Trius Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
K2 Therapeutics Inc CDTX
Employee Stock Option (right to buy) · derivative
|
2017-03-31 | Grant | 50,000 | $0.00 | |
|
K2 Therapeutics Inc CDTX
Stock Option (right to buy) · derivative
|
2016-03-16 | Grant | 50,000 | $0.00 | |
|
Trius Therapeutics Inc TSRX
Stock Option (right to buy) · derivative
|
2013-09-11 | Disposed to issuer | 90,000 | $7.37 | 663,300 |
|
Trius Therapeutics Inc TSRX
Common Stock
|
2013-09-11 | Disposed to issuer | 96,400 | ||
|
Trius Therapeutics Inc TSRX
Stock Option (right to buy) · derivative
|
2013-09-11 | Disposed to issuer | 75,000 | $8.70 | 652,500 |
|
Trius Therapeutics Inc TSRX
Stock Option (right to buy) · derivative
|
2013-09-11 | Disposed to issuer | 16,569 | $12.21 | 202,307 |
|
Trius Therapeutics Inc TSRX
Stock Option (right to buy) · derivative
|
2013-09-11 | Disposed to issuer | 6,395 | $12.21 | 78,083 |
|
Trius Therapeutics Inc TSRX
Stock Option (right to buy) · derivative
|
2013-09-11 | Disposed to issuer | 40,000 | $10.00 | 400,000 |
|
Trius Therapeutics Inc TSRX
Common Stock
|
2013-07-01 | Sell | 2,000 | $8.14 | 16,280 |
|
Trius Therapeutics Inc TSRX
Common Stock
|
2013-06-04 | Sell | 2,000 | $7.90 | 15,800 |
|
Trius Therapeutics Inc TSRX
Common Stock
|
2013-05-24 | Sell | 12,000 | $7.93 | 95,160 |
|
Trius Therapeutics Inc TSRX
Common Stock
|
2013-05-14 | Sell | 12,000 | $7.85 | 94,200 |
|
Trius Therapeutics Inc TSRX
Stock Option (right to buy) · derivative
|
2013-03-07 | Grant | 90,000 | $0.00 | |
|
Trius Therapeutics Inc TSRX
Stock Option (right to buy) · derivative
|
2012-03-08 | Grant | 75,000 | $0.00 |